Şevket Tolga Tombul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Şevket Tolga Tombul has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Demirtas
Department of Urology, Erciyes University, Kayseri, Turkey
27 shared publications - Gökhan Sönmez
Department of Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
23 shared publications - Türev Demirtaş
History of Medicine and Ethics, Erciyes University, Kayseri, TUR
17 shared publications - Abdullah Golbasi
Department of Urology, University of Health Sciences Medical Faculty of Kayseri, Kayseri City Hospital, Kayseri, Turkey
5 shared publications - Atila Tatlışen
Department of Urology, Erciyes University, Kayseri, Turkey
3 shared publications Gökhan Sönmez
3 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 1219-1226
Risk Factors for Sigmoid Colonic Anastomosis: A Comparative and Cross-Sectional Analysis
Objective: To evaluate the anastomotic leakage (AL) rates in cancerous and non-cancerous intestinal anastomoses and analyze the general risk factors for AL. Methods: The primary endpoint of this study is to investigate whether there is a difference in terms of AL between patients who underwent sigmoid colon resection + colorectal anastomosis due to primary colon cancer (Group 1) and patients with a completely healthy colorectal region who underwent sigmoid colon resection + colorectal anastomosis for use in the orthotopic bladder during radical cystoprostatectomy (Group 2). The secondary endpoint, considering all the patients, is to evaluate and investigate the risk factors affecting the AL rates. Results: A total of 178 patients, including 63 (35.4%) patients in Group 1 and 115 (64.6%) patients in Group 2, were included in the study. The mean age of all patients was 61.7 ± 9.9 years, and there was no statistical difference between the mean ages of the groups (62.8 ± 11.3 vs 60.7 ± 6.1, p = 0.106, respectively). Thirty-six (20.2%) of the patients were female, and 142 (79.8%) were male. There was no significant difference between the groups in terms of AL in the postoperative period. Postoperative AL was seen in three patients (4.8%) and six patients (5.2%) in Group 1 and Group 2, respectively (p = 0.642). According to univariate and multiple logistic regression analysis, the risk of AL increased in patients with comorbidities, in the presence of previous abdominal surgery, in patients with high neutrophil-to-lymphocyte ratio, and patients with postoperative ileus (p values are 0.042, 0.010, 0.029 and 0.048, respectively). Conclusion: Our data suggest that anastomosis due to colon cancer resection does not increase the risk of AL compared with healthy bowel anastomoses. In addition, some clinical factors have been found to compromise anastomotic safety and are risk factors for AL. In addition, some clinical factors have been found to endanger anastomotic safety and are risk factors for AL.
- 1 August 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 1219-1226
Open AccessRisk Factors for Sigmoid Colonic Anastomosis: A Comparative and Cross-Sectional Analysis
Objective: To evaluate the anastomotic leakage (AL) rates in cancerous and non-cancerous intestinal anastomoses and analyze the general risk factors for AL. Methods: The primary endpoint of this study is to investigate whether there is a difference in terms of AL between patients who underwent sigmoid colon resection + colorectal anastomosis due to primary colon cancer (Group 1) and patients with a completely healthy colorectal region who underwent sigmoid colon resection + colorectal anastomosis for use in the orthotopic bladder during radical cystoprostatectomy (Group 2). The secondary endpoint, considering all the patients, is to evaluate and investigate the risk factors affecting the AL rates. Results: A total of 178 patients, including 63 (35.4%) patients in Group 1 and 115 (64.6%) patients in Group 2, were included in the study. The mean age of all patients was 61.7 ± 9.9 years, and there was no statistical difference between the mean ages of the groups (62.8 ± 11.3 vs 60.7 ± 6.1, p = 0.106, respectively). Thirty-six (20.2%) of the patients were female, and 142 (79.8%) were male. There was no significant difference between the groups in terms of AL in the postoperative period. Postoperative AL was seen in three patients (4.8%) and six patients (5.2%) in Group 1 and Group 2, respectively (p = 0.642). According to univariate and multiple logistic regression analysis, the risk of AL increased in patients with comorbidities, in the presence of previous abdominal surgery, in patients with high neutrophil-to-lymphocyte ratio, and patients with postoperative ileus (p values are 0.042, 0.010, 0.029 and 0.048, respectively). Conclusion: Our data suggest that anastomosis due to colon cancer resection does not increase the risk of AL compared with healthy bowel anastomoses. In addition, some clinical factors have been found to compromise anastomotic safety and are risk factors for AL. In addition, some clinical factors have been found to endanger anastomotic safety and are risk factors for AL.
- Open Access
- 9 July 2024
- Published by Elsevier in Prostate International
- Vol. 12 (3) , 155-159
Does the type of the previous biopsy affect the fusion prostate biopsy results?
- 9 July 2024
- Published by Elsevier in Prostate International
- Vol. 12 (3) , 155-159
Open AccessDoes the type of the previous biopsy affect the fusion prostate biopsy results?
- Open Access
- 11 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22144
A Novel Modified Two-Lobe Holmium Prostate Enucleation Technique: Demirtaş–Erciyes Enucleation Prostatectomy
Endoscopic enucleation of the prostate has evolved and became popular for the surgical treatment of benign prostatic hyperplasia (BPH) during the last decade. Different surgical techniques have been described so far. We hereby described a new modified two-lobe technique for urologists who are inexperienced in endoscopic enucleation. We aimed here to present the data on a learning curve of this stepwise technique named Demirtaş-Erciyes Enucleation Prostatectomy (DEEP): reverse S-J incision technique and its postoperative outcomes. The study included 102 patients who underwent holmium laser enucleation of the prostate (HoLEP) with the DEEP technique between October 2020 and December 2021. Demographic, preoperative, and postoperative variables were recorded. The operation was performed with a 150 W holmium laser system (Quanta System, Varese, Italy) with cutting and coagulation settings of 2J × 50 Hz with virtual basket mode and 2J × 12 Hz in bubble blast mode, respectively. Bladder irrigation was done for one day, and then, on the next day, the urethral catheter was removed. Postoperatively, uroflowmetry studies, continence status, and ejaculation status were recorded during follow-up. The data of all patients were divided into two groups (first 51 and final 51 patients). All variables were analyzed between two groups. The mean age of the patients was 68.48±8.74 years. The median Charlson Comorbidity Index (CCI) score was 3. The median International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF) values were 26 (10-35) and 10 (0-25), respectively. Of the patients, 60.8% had Foley catheters due to urinary retention. The median anesthesia time, laser time, enucleation time, morcellation time, and enucleated tissue amount were 102.5 minutes, 17 minutes, 25 minutes, 20 minutes, and 50 g, respectively. Enucleation was performed in two stages in five patients due to bigger prostate volume or incomplete morcellation. The median catheter removal time was 48 hours. In six patients, the postoperative catheterization time was prolonged due to hematuria. The median increase in Qmax was 19.35 mL/second. The overall complication rate was 5.9%, which were all Clavien grade II. Enucleation time, laser time, and anesthesia time were significantly lower in the last 51 patients. DEEP enucleation technique seems to provide effective and safe postoperative results for beginners in prostate enucleation.
- 11 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22144
Open AccessA Novel Modified Two-Lobe Holmium Prostate Enucleation Technique: Demirtaş–Erciyes Enucleation Prostatectomy
Endoscopic enucleation of the prostate has evolved and became popular for the surgical treatment of benign prostatic hyperplasia (BPH) during the last decade. Different surgical techniques have been described so far. We hereby described a new modified two-lobe technique for urologists who are inexperienced in endoscopic enucleation. We aimed here to present the data on a learning curve of this stepwise technique named Demirtaş-Erciyes Enucleation Prostatectomy (DEEP): reverse S-J incision technique and its postoperative outcomes. The study included 102 patients who underwent holmium laser enucleation of the prostate (HoLEP) with the DEEP technique between October 2020 and December 2021. Demographic, preoperative, and postoperative variables were recorded. The operation was performed with a 150 W holmium laser system (Quanta System, Varese, Italy) with cutting and coagulation settings of 2J × 50 Hz with virtual basket mode and 2J × 12 Hz in bubble blast mode, respectively. Bladder irrigation was done for one day, and then, on the next day, the urethral catheter was removed. Postoperatively, uroflowmetry studies, continence status, and ejaculation status were recorded during follow-up. The data of all patients were divided into two groups (first 51 and final 51 patients). All variables were analyzed between two groups. The mean age of the patients was 68.48±8.74 years. The median Charlson Comorbidity Index (CCI) score was 3. The median International Prostate Symptom Score (IPSS) and International Index of Erectile Function (IIEF) values were 26 (10-35) and 10 (0-25), respectively. Of the patients, 60.8% had Foley catheters due to urinary retention. The median anesthesia time, laser time, enucleation time, morcellation time, and enucleated tissue amount were 102.5 minutes, 17 minutes, 25 minutes, 20 minutes, and 50 g, respectively. Enucleation was performed in two stages in five patients due to bigger prostate volume or incomplete morcellation. The median catheter removal time was 48 hours. In six patients, the postoperative catheterization time was prolonged due to hematuria. The median increase in Qmax was 19.35 mL/second. The overall complication rate was 5.9%, which were all Clavien grade II. Enucleation time, laser time, and anesthesia time were significantly lower in the last 51 patients. DEEP enucleation technique seems to provide effective and safe postoperative results for beginners in prostate enucleation.
- 1 January 2022
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 39 (1) , 51-55
Demirtas’ early renal vascular control technique (DERVACT): A novel technique for open partial nephrectomy
“Demirtas’ Early Renal Vascular Control Technique (DERVACT)” is a novel technique for renal pedicle control that aims to achieve rapid and direct access to the renal artery through the retroperitoneal space and then the superior-dorso-lateral aspect of the kidney. In this study, we aimed to introduce DERVACT and to present the initial outcomes of this technique. This retrospective-observational study compared two groups of patients that were operatively treated by the same surgical team using two different nephron sparing surgery (NSS) procedures. Group I (n=95) underwent standard open NSS and Group II (n=92) underwent open NSS with the DERVACT between Jan 2015 and July 2020. Mean age was 56.42 ± 13.27 years. No significant difference was found between the two groups with regard to age, gender, Body mass index, mass laterality and size, and the Padua and c-index scores (p=0.087, p=0.354, p=0.642, p=0.957, p=0.200, p=0.101, p=0.361, respectively). Similarly, no significant difference was found between the DERVACT group and the other group with regard to ischemia duration (20.0 [15.0-30.0] min vs. 18.5 [11.0-27.0] min, respectively, p=0.060) and intraoperative vascular complication rate (6.3% vs. 1.1%, respectively. p=0.059). However, non-ischemic operative time was significantly shorter in the DERVACT group than in the standard partial nephrectomy group (64.0 [50.0-75.0] vs. 84.0 [61.0-105.0], p<0.001). As a conclusion, DERVACT is a simple, time-saving, and safe procedure for NSS that can be used in clinics with no opportunities for robotic-laparoscopic partial nephrectomy or in open partial nephrectomy.
- 1 January 2022
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 39 (1) , 51-55
Demirtas’ early renal vascular control technique (DERVACT): A novel technique for open partial nephrectomy
“Demirtas’ Early Renal Vascular Control Technique (DERVACT)” is a novel technique for renal pedicle control that aims to achieve rapid and direct access to the renal artery through the retroperitoneal space and then the superior-dorso-lateral aspect of the kidney. In this study, we aimed to introduce DERVACT and to present the initial outcomes of this technique. This retrospective-observational study compared two groups of patients that were operatively treated by the same surgical team using two different nephron sparing surgery (NSS) procedures. Group I (n=95) underwent standard open NSS and Group II (n=92) underwent open NSS with the DERVACT between Jan 2015 and July 2020. Mean age was 56.42 ± 13.27 years. No significant difference was found between the two groups with regard to age, gender, Body mass index, mass laterality and size, and the Padua and c-index scores (p=0.087, p=0.354, p=0.642, p=0.957, p=0.200, p=0.101, p=0.361, respectively). Similarly, no significant difference was found between the DERVACT group and the other group with regard to ischemia duration (20.0 [15.0-30.0] min vs. 18.5 [11.0-27.0] min, respectively, p=0.060) and intraoperative vascular complication rate (6.3% vs. 1.1%, respectively. p=0.059). However, non-ischemic operative time was significantly shorter in the DERVACT group than in the standard partial nephrectomy group (64.0 [50.0-75.0] vs. 84.0 [61.0-105.0], p<0.001). As a conclusion, DERVACT is a simple, time-saving, and safe procedure for NSS that can be used in clinics with no opportunities for robotic-laparoscopic partial nephrectomy or in open partial nephrectomy.
- 1 January 2022
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 46 (1) , 35-40
Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer
- 1 January 2022
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 46 (1) , 35-40
Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer
- Open Access
- 17 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11) , e19663
Risk Factors for Early Urethral Stricture After Mono-Polar Transurethral Prostate Resection: A Single-Center Experience
This study aimed to investigate the incidence of urethral stricture during the early period after transurethral resection of the prostate (TURP) and the risk factors affecting the development of urethral stricture in patients treated in our clinic. This retrospective study included patients who underwent TURP due to benign prostate hyperplasia (BPH) and had complete postoperative follow-up data of at least 12 months. Univariate and multivariate logistic regression analyses were performed to evaluate the relationship between urethral stricture and eight parameters (age, body mass index [BMI], prostate volume, number of comorbidities, amount of tissue removed, operative time, perioperative blood loss, and catheterization duration). Of the 3069 patients who underwent TURP in our clinic during the study period, 1740 patients with complete clinical data were included in the study. Mean age was 67.83 ± 5.80 years and mean body mass index (BMI) was 27.63 ± 4.31 kg/m2. Median preoperative prostate volume was 50.0 (range, 41.0-62.0) mm3 and the average amount of tissue removed during surgery was 20.0 (range, 12.0-30.0) g. Urethral stricture was detected in 3.9% (67/1740) of the patients during a minimum of 12 months of follow-up period after TURP. In multivariate analysis, prolonged operative time and high comorbidity burden were found to be risk factors for urethral stricture (p<0.001 for both). Early urethral stricture remains an important complication of TURP. Our results show that prolonged operative time and high comorbidity burden are factors that increase the risk of urethral stricture.
- 17 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11) , e19663
Open AccessRisk Factors for Early Urethral Stricture After Mono-Polar Transurethral Prostate Resection: A Single-Center Experience
This study aimed to investigate the incidence of urethral stricture during the early period after transurethral resection of the prostate (TURP) and the risk factors affecting the development of urethral stricture in patients treated in our clinic. This retrospective study included patients who underwent TURP due to benign prostate hyperplasia (BPH) and had complete postoperative follow-up data of at least 12 months. Univariate and multivariate logistic regression analyses were performed to evaluate the relationship between urethral stricture and eight parameters (age, body mass index [BMI], prostate volume, number of comorbidities, amount of tissue removed, operative time, perioperative blood loss, and catheterization duration). Of the 3069 patients who underwent TURP in our clinic during the study period, 1740 patients with complete clinical data were included in the study. Mean age was 67.83 ± 5.80 years and mean body mass index (BMI) was 27.63 ± 4.31 kg/m2. Median preoperative prostate volume was 50.0 (range, 41.0-62.0) mm3 and the average amount of tissue removed during surgery was 20.0 (range, 12.0-30.0) g. Urethral stricture was detected in 3.9% (67/1740) of the patients during a minimum of 12 months of follow-up period after TURP. In multivariate analysis, prolonged operative time and high comorbidity burden were found to be risk factors for urethral stricture (p<0.001 for both). Early urethral stricture remains an important complication of TURP. Our results show that prolonged operative time and high comorbidity burden are factors that increase the risk of urethral stricture.
- Open Access
- 24 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
A Prospective Study and Single Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients
Fusion prostate biopsy (FPB) has become a popular technique in biopsy-naïve patients, though not accepted as a standard approach (yet). In this study, we aimed to present the clinical outcomes of biopsy-naïve patients who underwent FPB. The study included 400 biopsy-naïve patients aged 45-75 years who had a prostate-specific antigen (PSA) level of 2-10 ng/ml and were detected with a Prostate Imaging-Reporting and Data System (PIRADS) ≥3 lesion on multiparametric prostate magnetic resonance imaging (mpMRI)-guided FPB. A combined biopsy (CB) was performed in each patient, in which 2-4 cores were obtained for suspicious lesions by targeted biopsy (TB) and then 12-core standard prostate biopsy (SPB) was conducted in the same session. Cancer detection rates, clinically significant prostate cancer (csPCa) detection rates, histological upgrading rates, and false negative rates were determined. The 400 patients had a mean age of 62.01±7.00 years and a mean PSA value of 6.84±1.87 ng/ml. Overall PCa detection rate was 50% (200/400). The csPCa detection rates for TB, SPB, and CB were 25.0%, 31.8%, and 44.0%, respectively (p<0.001). In PIRADS 3, 4, and 5 lesions, CB had a csPCa detection rate of 29.2%, 54%, and 64.8%, respectively (p<0.001). The ratio of false negativity was significantly higher for TB compared to SPB (43.2% vs. 27.8%, p=0.003), whereas no significant difference was found between these two techniques with regard to upgrading rates although TB had a higher rate (19.6% vs. 13.7%, p=0.144). FPB, a combined approach involving TB and SPB, was revealed as the most successful technique in biopsy-naïve patients with PSA<10 ng/ml due to its high cancer detection rates and low false negative rates.
- 24 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Open AccessA Prospective Study and Single Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients
Fusion prostate biopsy (FPB) has become a popular technique in biopsy-naïve patients, though not accepted as a standard approach (yet). In this study, we aimed to present the clinical outcomes of biopsy-naïve patients who underwent FPB. The study included 400 biopsy-naïve patients aged 45-75 years who had a prostate-specific antigen (PSA) level of 2-10 ng/ml and were detected with a Prostate Imaging-Reporting and Data System (PIRADS) ≥3 lesion on multiparametric prostate magnetic resonance imaging (mpMRI)-guided FPB. A combined biopsy (CB) was performed in each patient, in which 2-4 cores were obtained for suspicious lesions by targeted biopsy (TB) and then 12-core standard prostate biopsy (SPB) was conducted in the same session. Cancer detection rates, clinically significant prostate cancer (csPCa) detection rates, histological upgrading rates, and false negative rates were determined. The 400 patients had a mean age of 62.01±7.00 years and a mean PSA value of 6.84±1.87 ng/ml. Overall PCa detection rate was 50% (200/400). The csPCa detection rates for TB, SPB, and CB were 25.0%, 31.8%, and 44.0%, respectively (p<0.001). In PIRADS 3, 4, and 5 lesions, CB had a csPCa detection rate of 29.2%, 54%, and 64.8%, respectively (p<0.001). The ratio of false negativity was significantly higher for TB compared to SPB (43.2% vs. 27.8%, p=0.003), whereas no significant difference was found between these two techniques with regard to upgrading rates although TB had a higher rate (19.6% vs. 13.7%, p=0.144). FPB, a combined approach involving TB and SPB, was revealed as the most successful technique in biopsy-naïve patients with PSA<10 ng/ml due to its high cancer detection rates and low false negative rates.
- 8 July 2021
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (1) , 21-24
Evaluation of Urine Polymerase Chain Reaction Test Positivity Rates and the Effectiveness of Positron Emission Tomography in Renal Involvement in Patients with Active COVID-19 Infection: A Prospective and Multidisciplinary Study
- 8 July 2021
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (1) , 21-24
Evaluation of Urine Polymerase Chain Reaction Test Positivity Rates and the Effectiveness of Positron Emission Tomography in Renal Involvement in Patients with Active COVID-19 Infection: A Prospective and Multidisciplinary Study
- Open Access
- 1 May 2021
- Published by Elsevier in Urology Case Reports
- Vol. 36, 101597
The ectopic ureter opening into the vulva, which is a rare cause of lifelong urinary incontinence: Treatment with ureteroureterostomy
- 1 May 2021
- Published by Elsevier in Urology Case Reports
- Vol. 36, 101597
Open AccessThe ectopic ureter opening into the vulva, which is a rare cause of lifelong urinary incontinence: Treatment with ureteroureterostomy